<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02940509</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00006048</org_study_id>
    <nct_id>NCT02940509</nct_id>
  </id_info>
  <brief_title>Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids</brief_title>
  <official_title>The Role of Ketamine and Magnesium in Post-operative Pain Control After Laparoscopic Surgery in Patients With Chronic Pelvic Pain Treated With Opioids: A Double-Blinded Randomized Control Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research proposal is to determine if the intraoperative administrative of
      Ketamine and Magnesium during laparoscopic gynecologic surgery improves postoperative pain in
      patients on chronic opioid therapy for management of chronic pelvic pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized control trial, patients' postoperative pain scores will be assessed as
      scored by the Numeric Rating Score (NRS) system. Intraoperative and postoperative narcotic
      usage, nausea scores and patients' perception of their quality of recovery via the QoR-40
      survey will also be assessed.

      The use of intraoperative Ketamine and Magnesium is predicted to decrease postoperative pain
      in patients on chronic opioid therapy for management of chronic pelvic pain and will overall
      improve patients' postoperative experience.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain score using the Numeric Rating Scale (NRS)</measure>
    <time_frame>1st 24 hours post-op</time_frame>
    <description>Patient described pain level on a scale of 0-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative opioid use</measure>
    <time_frame>24 hours post operative</time_frame>
    <description>Dilaudid and Oxycodone in mg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Questionnaire</measure>
    <time_frame>3-5 days post operative</time_frame>
    <description>Patient perception of quality of recovery as measured by the QoR-40 Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fentanyl use</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Amount of fentanyl used intra-operatively in mcg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea Scores using PONV Impact Scale Score</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Patient described nausea level using 2 questions each with 4 answers with numerical value from 0-3. To calculate the PONV Impact Scale score, the numerical responses to questions 1 and 2 are added to obtain the PONV impact scale score. A PONV Impact Scale score of â‰¥5 defines clinically important PONV.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Number of days the patient was an inpatient in the hospital.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Ketamine plus Magnesium sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketamine 0.5mg/kg IV dose with 2g magnesium IV dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal Saline (NaCl 0.9%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine plus Magnesium sulfate</intervention_name>
    <description>Patients will receive 2 IV infusions:
Ketamine (0.5mg/kg)
Magnesium sulfate (2g)</description>
    <arm_group_label>Ketamine plus Magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients will receive 2 IV infusions, both of NaCl 0.9%, as placebos for Ketamine and magnesium sulfate</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>2 placebo infusions</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects undergoing elective laparoscopic gynecologic surgery

          2. Patients with chronic pelvic pain defined as pain that has persisted for more than 6
             months in duration which is localized to the pelvis, anterior abdominal wall, lower
             back or buttocks and has leads to functional disability or medical care1

          3. Patients requiring opioids daily for &gt;1 month

          4. Consenting adults age 18-80

          5. American Society of Anesthesiologists (ASA) Physical Status classification II to ASA
             III

        Exclusion Criteria:

          1. Patient refusal

          2. Chronic Kidney disease (Creatinine&gt;2)

          3. Patients treated with methadone

          4. Known allergy or adverse effect of ketamine or magnesium

          5. Patient unable to give informed consent

          6. Patient with limited or no English fluency

          7. Uncontrolled hypertension
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stacey Duryea, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stacey Duryea, DO</last_name>
    <phone>717-531-6140</phone>
    <email>sduryea@pennstatehealth.psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yonghee Cho, MD</last_name>
    <email>ycho2@pennstaehealth.psu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stacey Duryea, DO</last_name>
      <phone>717-531-6140</phone>
      <email>sduryea@pennstatehealth.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Yonghee Cho, MD</last_name>
      <email>ycho2@pennstatehealth.psu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2016</study_first_submitted>
  <study_first_submitted_qc>October 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Stacey Duryea</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

